Both in Biotechnology
Alector vs SAB Biotherapeutics
Over the past year ALEC returned +22.0% and SABS returned −6.3%; their daily moves had a correlation of 0.27.
ALEC +22.0% SABS −6.3%Growth of $1, one year, split-adjusted
| Metric | ALEC | SABS |
|---|---|---|
| Price | $1.83 | $2.84 |
| Market cap | $204.3M | $258.4M |
| Today | 0.00% | −6.58% |
| 1 month | −4.7% | −15.2% |
| 6 months | −24.1% | −19.3% |
| Year to date | +17.3% | −24.1% |
| 1 year | +13.7% | −5.3% |
| Revenue growth (YoY) | −57.8% | — |
| Gross margin | 100.0% | — |
| Net margin | −692.5% | — |
| P/E (TTM) | — | — |
| Price / sales | 14.7× | — |
| Net cash | $162.9M | $99.4M |
| Dividend yield | — | — |
| Volatility (60d) | 98.9% | 52.4% |
| Short % of float | 6.7% | 5.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).